The motivation behind applying for the membership of the prestigious EASL-CLIF Consortium resides in our continuous strive for improving the quality of care to our patients suffering from end-stage liver disease. As a tertiary referral hospital with relatively high inflow of patients with advanced chronic liver disease, originating from middle and northern regions of Romania, we take pride in providing a complex series of techniques for evaluating and treating liver diseases (i.e., transient elastography, transjugular liver biopsy, transjugular intrahepatic portosystemic shunt (TIPS)). The recent introduction of a transplant program at our institution opens new avenues in terms of national/international collaborations. All the above considered, the adherence to the EASL-CLIF Consortium will expand these collaborations and add high value to our research.